Haplotype mismatched transplantation using high doses of peripheral blood CD34+ cell together with stratified conditioning regimens for high-risk adult acute myeloid leukemia patients: A pilot study in a single Korea institution

Bone Marrow Transplantation

Volumn 35, Issue 10, 2005, Pages 959-964

  Kim, H J ^a   Min, W S ^a   Kim, Y J ^a   Kim, D W ^a   Lee, J W ^a   Kim, C C ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Haploidentical transplantation; High risk AML; Immune recovery; NL alloreactivity

Indexed keywords

BUSULFAN; CD34 ANTIGEN; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; HLA ANTIGEN; METHOTREXATE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOIMMUNITY; ARTICLE; CANCER MORTALITY; CANCER REGRESSION; CANCER RELAPSE; CANCER SURVIVAL; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; FEMALE; FOLLOW UP; GRAFT INFECTION; GRAFT VERSUS HOST REACTION; HAPLOTYPE; HIGH RISK PATIENT; HLA MATCHING; HUMAN; KOREA; MALE; NATURAL KILLER CELL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PILOT STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT PLANNING; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ANTIGENS, CD34; CHILD; FEMALE; GRAFT VS HOST DISEASE; HAPLOTYPES; HISTOCOMPATIBILITY TESTING; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PILOT PROJECTS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 19044393042     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704900     Document Type: Article

References (19)

1. Chao NJ, Koh LP, Long GD et al. Adult recipients of umbilical cord blood transplants after nonmyeloablative preparative regimens. Biol Blood Marrow Transplant 2004; 10: 569-575.
2. Chao NJ, Koh LP. Umbilical cord blood transplantation in adults using myeloablative and nonmyeloablative preparative regimens. Biol Blood Marrow Transplant 2004; 10: 1-22.
3. Aversa F, Tabilio A, Terenzi A et al. Successful engraftment of T-cell-depleted haploidentical 'Three-loci' incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 1994; 84: 3948-3955.
4. Aversa F, Tabilio A, Velardi A et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from relapsed donors with one fully mismatched HLA haplotype. N Engl J Med 1998; 339: 1186-1193.
5. Aversa F, Terenzi A, Carotti A et al. Improved outcome with T-cell-depleted bone marrow transplantation for acute leukemia. J Clin Oncol 1999; 17: 1545-1550.
6. Martelli MF, Reisner Y. Haploidentical 'megadose' CD34+ cell transplants for patients with acute leukemia. Leukemia 2002; 16: 404-405.
7. Rachamim N, Gan J, Segall H et al. Tolerance induction by "Megadose" hematopoietic transplants. Transplantation 1998; 65: 1386-1393.
8. Handgretinger R, Schumm M, Lang P et al. Transplantation of megadoses of purified haploidentical stem cells. Ann NY Acad Sci 1999; 872: 351-361.
9. Kim HJ, Park CY, Park YH et al. Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients. Bone Marrow Transplant 2003; 31: 79-86.
10. Aversa F, Terenzi A, Felicini R et al. Haploidentical stem cell transplantation for acute leukemia. Int J Hematol 2002; 76 (Suppl. 1): 165-168.
11. Aversa F, Terenzi A, Ballanti S et al. Improving outcomes of haploidentical transplants for acute leukemia. Biol Blood Marrow Transpl 2003; 9: 9a.
12. Kim HJ, Park SJ, Im HW et al. The association of HLA antigen and GvHD in allogeneic hemopoietic stem cell transplantation with histocompatible sibling donor: a single-center experience in Korea. Int J Hematol 2002; 76: 267-271.
13. Fry TJ, Mackall CL. Interleukin-7: from bench to clinic. Blood 2002; 99: 3892-3904.
14. Min D, Taylor PA, Panoskaltsis-Mortari A et al. Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood 2002; 99: 4592-4600.
15. Ruggeri L, Capanni M, Volpi I et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 1999; 94: 333-339.
16. Ruggeri L, Capanni M, Urbani E et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295: 2097-2100.
17. Slovak ML, Kopecky KJ, Cassileth PA et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study. Blood 2000; 96: 4075-4083.
18. van Rood JJ, Loberiza Jr FR, Zhang MJ et al. Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling. Blood 2002; 99: 1572-1577.
19. Shimazaki C, Ochiai N, Uchida R et al. Non-T-cell depleted HLA haploidentical stem cell transplantation in advanced hematologic malignancies based on the feto-maternal michrochimerism. Blood 2003; 101: 3334-3336.